Ending the HIV/HCV Epidemics in Indian Country
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This contract focuses on a program designed to support communities in increasing the diagnosis, treatment, and prevention of HIV, hepatitis C virus (HCV), and syphilis, with a specific emphasis on the American Indian/Alaska Native (AI/AN) population. The program aims to reduce new infections and related health disparities by implementing effective, innovative strategies and services within these communities. The initiative is structured into four interconnected parts, all targeting improvements in health outcomes associated with these infections. The primary goals of the program are to reduce new HIV, HCV, and syphilis infections to fewer than 3,000 annually by 2030, and to achieve significant reductions in HCV infections and mortality rates compared to 2015 baselines—specifically, a 90 percent decrease in new HCV cases and a 65 percent reduction in mortality. The project is managed by the Indian Health Service under the Department of Health and Human Services, with the Division of Grants Management serving as the point of contact. This initiative represents a comprehensive effort to address and curb the epidemics within Indian Country through targeted public health interventions.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
The purpose of this program is to support communities to directly increase the diagnoses, treatment, and prevention of HIV, HCV, and syphilis. Successful applicants will work toward a re-duction of new HIV infections and relevant co-morbidities, specifically syphilis and HCV infections; improve HIV/HCV/syphilis-related health outcomes; and reduce HIV/HCV/syphilis-related health disparities among the AI/AN population. In four separate but related parts, this initiative aims to implement effective and innovative strategies, interventions, approaches, and services to reduce new HIV/HCV/syphilis infections among AI/AN communities in the U.S. This initiative’s overarching goals are to: (1) Reduce new HIV, HCV, and syphilis infections to less than 3,000 per year by 2030; and (2) achieve a 90 percent reduction in new HCV infections and a 65 percent reduction in mortality, compared to a 2015 baseline.
